Back to Authors

Kim, Yonghyun

0000-0001-6344-1258

Mayo Clinic

Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, AL 35487, USA. ykim@eng.ua.edu.

Citations 2

Peptide-mediated targeted delivery of SOX9 nanoparticles into astrocytes ameliorates ischemic brain injury
Shin, Hyo Jung , Choi, Seung Gyu , Qu, Fengrui , Yi, Min‐Hee , Kim, Sang Ryong , Kim, Hyeong-Geug , Beom, Jaewon , Yi, Yoon Young , Joe, Eun-hye , Beom, Jaewon , Song, Hee-Jung , Kim, Yonghyun , Kim, Dong Woon , Lee, Choong‐Hyun , Yi, Yoonyoung, Kim, Do Kyung , Kim, Yonghyun , Kim, Dong Woon

Nanoscale | November 30, 2023 | Volume: 16 | Issue: 2 | Pages: 833-847

10.1039/d3nr01318a Get It

We describes the development of a poly-lactic-coglycolic acid (PLGA) nanoparticle-based system for conjugation of targeting peptides to PLGA nanoparticles and delivery of the therapeutic gene SOX9 to damaged astrocytes in a mouse stroke model.
Uncoupled Endothelial Nitric Oxide Synthase Enhances p-Tau in Chronic Traumatic Encephalopathy Mouse Model
Shin, Nara , Kim, Hyeong-Geug , Kwon, Hyeok Hee , Yi, Min‐Hee , Zhang, Enji, Kim, Jwa-Jin, Hong, Jinpyo , Lee, Sun Yeul , Lee, Won Hyung , Triantafillu, Ursula L., Kim, Cuk‐Seong , Kim, Yonghyun , Kim, Dong Woon , Kim, Yonghyun , Kim, Dong Woon , Shin, Hyo Jung , Kim, Sena , Baek, Hyunjung

Antioxidants & Redox Signaling | August 2, 2018 | Volume: 30 | Issue: 13 | Pages: 1601-1620

10.1089/ars.2017.7280 Get It

Aims: Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease thought to be caused by repetitive traumatic brain injury (TBI) and subconcussive injuries. While hyperphosphorylation of tau (p-Tau), which is attributed to astrocytic tangles (ATs) and neurofibrillary tangles, is known to be involved in CTE, there are limited neuropathological or molecular data. By utilizing repetitive mild TBI (rmTBI) mouse models, our aim was to examine the pathological changes of CTE-associated structures, specifically the ATs. Results: Our rmTBI mouse models showed symptoms of depressive behavior and memory deficit, alongside an increased p-Tau expression in their neurons and astrocytes in both the hippocampus and cortex. rmTBI induced oxidative stress in endothelial cells and nitric oxide (NO) generation in astrocytes, which were mediated by hypoxia and increased hypoxia-inducible factor 1-α (HIF1α). There was also correlated decreased regional cerebral tissue perfusion units, mild activation of astrocytes and NFκB phosphorylation, increased expression of inducible nitric oxide synthase (iNOS), increased endothelial nitric oxide synthase (eNOS) uncoupling with decreased tetrahydrobiopterin, and increased expression of nitrotyrosine, NADPH oxidase 2 (Nox2)/nuclear factor (erythroid-derived 2) factor 2 (Nrf2) signaling proteins. Combined, these effects induced peroxynitrite formation and hyperphosphorylation of tau in the hippocampus and cortex toward the formation of ATs. Innovation: Our model features molecular pathogenesis events of CTE with clinically relevant latency periods. In particular, this is the first demonstration of an increased astrocytic iNOS expression in an in vivo model. Conclusion: We propose a novel mechanism of uncoupled eNOS and NO contribution to Tau phosphorylation and AT formation in rmTBI brain, toward an increased molecular understanding of the pathophysiology of human CTE.